Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Apr 12;15(1):12666.
doi: 10.1038/s41598-025-96631-1.

Suboptimal adherence to antiretroviral treatment and its predictors among people living with HIV in the era of test and treat

Affiliations
Multicenter Study

Suboptimal adherence to antiretroviral treatment and its predictors among people living with HIV in the era of test and treat

Ismael Ahmed et al. Sci Rep. .

Abstract

Despite the success in scaling-up antiretroviral therapy (ART) services in Ethiopia, suboptimal adherence to ART has been an existing challenge. There is a dearth of evidence on the status of adherence to ART following the adoption of test and treat strategy in Ethiopia. This study aimed to investigate on the magnitude of suboptimal adherence and its predictors among patients taking ART. A multicenter prospective cohort study was conducted among adults aged 15 years and above who started ART between March and June 2019 in 39 health facilities (HFs) in Ethiopia. Measurements on sociodemographic, behavioral, and clinical characteristics were taken at baseline and 6- and 12-months following ART initiation. Multivariable logistic regression model using generalized estimating equations was used to identify factors associated with suboptimal adherence. In total, 1229 individuals who started ART were included in the study. The proportion of suboptimal adherence was 8.0% and 7.9% at 6- and 12-months, respectively. Younger age (adjusted odds ratio (AOR) = 2.28 (95% confidence interval (CI) 1.10, 4.74)), being single (AOR = 2.08 (95% CI 1.25, 3.48)), and being a farmer (AOR = 3.21 (95% CI 1.84, 5.61)) were associated with increased risk for suboptimal adherence. Similarly, alcohol intake (AOR = 3.31 (95% CI 2.14, 5.11)), missing clinic appointment (AOR = 5.73 (95% CI 3.76, 8.75)), having opportunistic infections (AOR = 2.86 (95% CI 1.67, 4.88)) and presence of comorbidities (AOR = 3.51 (95% CI 1.89, 6.53)) were associated with higher risk for suboptimal adherence. We observed lower rate of suboptimal adherence to ART following the implementation of test and treat strategy in Ethiopia. Various sociodemographic, clinical, and behavioral factors were found to be independent predictors of suboptimal adherence. The findings highlight the importance of person-centered adherence support based on individual characteristics.

Keywords: Adherence to ART; Africa; Antiretroviral therapy; Ethiopia; HIV; Test and treat.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Schematic presentation of study participants enrolment. (*) At sixth and 12th month follow-up, 53 and 7 cases missed interview respectively, but reported to be on ART (active).

Similar articles

References

    1. MoH. Annual performance report. Ethiopia (2022).
    1. Bezabhe, W. M., Chalmers, L., Bereznicki, L. R. & Peterson, G. M. Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine (Baltimore)95(15), e3361 (2016). - PMC - PubMed
    1. Waju, B., Dube, L., Ahmed, M. & Assefa, S. S. Unsuppressed viral load level in public health facilities: Nonvirological predictors among adult antiretroviral therapy users in Southwestern Ethiopia. HIV AIDS (Auckl).13, 513–526 (2021). - PMC - PubMed
    1. Desta, A. A. et al. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect. Dis.20(1), 4 (2020). - PMC - PubMed
    1. MoH. National guidelines for comprehensive HIV prevention, care and treatment (2022).

Publication types

Substances

LinkOut - more resources